Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Theseus Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 72
- +25 vs. Q4 2022
- Shares held
- 39.5M
- +6.41M (+19.4%) vs. Q4 2022
- Total value
- $350.6M
- +$185.8M (+112.7%) vs. Q4 2022
- New holders
- 27
- 22 more added
- Sold out
- 2
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Middle East FZE | 16 | $142 | 0.00% | +16 | New |
| Psagot Value Holdings Ltd. / (Israel) | 274 | $2.00K | 0.00% | +274 | New |
| Ameritas Investment Partners, Inc. | 889 | $7.89K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,029 | $9.00K | 0.00% | −1,888−64.7% | Reduced |
| Metropolitan Life Insurance Co | 1,126 | $10.0K | 0.00% | +1,126 | New |
| Legal & General Group Plc | 1,433 | $12.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,418 | $13.0K | 0.00% | −3,732−72.5% | Reduced |
| Nisa Investment Advisors, LLC | 1,660 | $15.0K | 0.00% | +1,660 | New |
| Amalgamated Bank | 1,796 | $16.0K | 0.00% | −105−5.5% | Reduced |
| STRS Ohio | 2,700 | $23.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,793 | $24.8K | 0.00% | +2,793 | New |
| Wells Fargo & Company | 3,007 | $26.7K | 0.00% | +3,007 | New |
| California State Teachers Retirement System | 6,317 | $56.1K | 0.00% | −466−6.9% | Reduced |
| UBS Group AG | 6,851 | $60.8K | 0.00% | +2,207+47.5% | Added |
| American International Group, Inc. | 8,201 | $72.8K | 0.00% | +164+2.0% | Added |
| New York State Common Retirement Fund | 9,552 | $84.8K | 0.00% | +10.0% | Added |
| MetLife Investment Management | 10,330 | $91.7K | 0.00% | +10,330 | New |
| Deutsche Bank AG | 10,644 | $94.5K | 0.00% | +1,122+11.8% | Added |
| Barclays PLC | 12,993 | $115.4K | 0.00% | +4,089+45.9% | Added |
| JPMorgan Chase & Co | 13,037 | $116.0K | 0.00% | +3,398+35.3% | Added |
| Jump Financial, LLC | 15,859 | $140.8K | 0.01% | +15,859 | New |
| Gsa Capital Partners LLP | 17,543 | $156.0K | 0.02% | +17,543 | New |
| Cubist Systematic Strategies, LLC | 18,081 | $160.6K | 0.00% | +18,081 | New |
| Nuveen Asset Management, LLC | 21,849 | $194.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 25,822 | $229.0K | 0.00% | +820+3.3% | Added |
| Two Sigma Advisers, LP | 28,400 | $252.2K | 0.00% | +28,400 | New |
| Hudson Bay Capital Management LP | 35,000 | $310.8K | 0.00% | +35,000 | New |
| Morgan Stanley | 41,887 | $372.0K | 0.00% | +30,409+264.9% | Added |
| Charles Schwab Investment Management Inc | 45,111 | $400.6K | 0.00% | +1,784+4.1% | Added |
| Bank of New York Mellon Corp | 51,862 | $460.5K | 0.00% | +8,369+19.2% | Added |
| Two Sigma Investments, LP | 74,089 | $657.9K | 0.00% | +56,914+331.4% | Added |
| Tekla Capital Management LLC | 75,000 | $666.0K | 0.03% | −25,000−25.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 78,369 | $695.9K | 0.01% | +78,369 | New |
| Manufacturers Life Insurance Company, The | 79,751 | $708.2K | 0.00% | +23,683+42.2% | Added |
| Millennium Management LLC | 80,035 | $711.0K | 0.00% | +80,035 | New |
| Affinity Asset Advisors, LLC | 98,221 | $872.2K | 0.34% | +98,221 | New |
| Velan Capital Investment Management LP | 100,000 | $888.0K | 0.79% | +100,000 | New |
| TD Asset Management Inc | 106,948 | $949.7K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 110,715 | $983.1K | 0.02% | +110,715 | New |
| Wellington Management Group LLP | 111,612 | $991.1K | 0.00% | +111,612 | New |
| Altium Capital Management LP | 112,614 | $1.00M | 0.60% | +112,614 | New |
| Renaissance Technologies LLC | 130,600 | $1.16M | 0.00% | +111,800+594.7% | Added |
| DAFNA Capital Management LLC | 131,025 | $1.16M | 0.35% | +49,166+60.1% | Added |
| Northern Trust Corp | 133,460 | $1.19M | 0.00% | +159+0.1% | Added |
| Ensign Peak Advisors, Inc | 142,598 | $1.27M | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 143,980 | $1.28M | 0.02% | −90,022−38.5% | Reduced |
| Alliancebernstein L.P. | 154,317 | $1.37M | 0.00% | +154,317 | New |
| Bank of America Corp | 179,202 | $1.59M | 0.00% | +164,582+1,125.7% | Added |
| Walleye Capital LLC | 179,550 | $1.59M | 0.03% | −18,697−9.4% | Reduced |
| Laurion Capital Management LP | 179,619 | $1.60M | 0.07% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 226,201 | $2.01M | 0.03% | +226,201 | New |
| State Street Corp | 296,864 | $2.64M | 0.00% | +25,383+9.3% | Added |
| Candriam Luxembourg S.C.A. | 323,816 | $2.65M | 0.02% | +323,816 | New |
| Geode Capital Management, LLC | 327,870 | $2.91M | 0.00% | +28,264+9.4% | Added |
| Boxer Capital, LLC | 350,000 | $3.11M | 0.15% | −65,000−15.7% | Reduced |
| Rock Springs Capital Management LP | 437,329 | $3.88M | 0.09% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 460,728 | $4.07M | 0.00% | +460,728 | New |
| Citadel Advisors LLC | 484,386 | $4.30M | 0.00% | +484,386 | New |
| Opaleye Management Inc. | 488,100 | $4.33M | 1.30% | −46,900−8.8% | Reduced |
| Nextech Invest AG | 611,310 | $5.43M | 2.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 700,961 | $6.22M | 0.00% | +62,489+9.8% | Added |
| Omega Fund Management, LLC | 711,479 | $6.32M | 4.12% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 761,258 | $6.76M | 5.64% | −22,900−2.9% | Reduced |
| VR Adviser, LLC | 770,000 | $6.84M | 1.34% | +770,000 | New |
| BlackRock Inc. | 883,462 | $7.85M | 0.00% | +18,405+2.1% | Added |
| FMR LLC | 1,113,662 | $9.89M | 0.00% | −1,384,693−55.4% | Reduced |
| Price T Rowe Associates Inc | 1,325,565 | $11.8M | 0.00% | +11,657+0.9% | Added |
| Paradigm Biocapital Advisors LP | 1,505,327 | $13.4M | 1.27% | +1,505,327 | New |
| Fairmount Funds Management LLC | 1,865,671 | $16.6M | 2.85% | +1,865,671 | New |
| Frazier Life Sciences Management, L.P. | 2,248,194 | $20.0M | 1.45% | +850,000+60.8% | Added |
| Foresite Capital Management V, LLC | 3,585,346 | $31.8M | 23.54% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 17,233,668 | $153.0M | 3.03% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |